Critical Reviews in Oncology / Hematology
Volume 75, Issue 3 , Pages 243-248 , September 2010

Identifying an accurate pre-screening tool in geriatric oncology

  • Eliane Kellen

      Affiliations

    • Leuven Centre of Cancer Prevention, University Hospitals - Leuven, Belgium
    • Corresponding Author InformationCorresponding author at: Leuven Centre of Cancer Prevention, University Hospitals - Leuven, Belgium. Tel.: +32 016 33 74 93; fax: +32 016 33 74 80.
  • ,
  • Paul Bulens

      Affiliations

    • Limburg Oncology Centre – Hasselt, Belgium
  • ,
  • Laura Deckx

      Affiliations

    • Department of General Practice and Research Institute Caphri, Maastricht University, The Netherlands
  • ,
  • Harry Schouten

      Affiliations

    • Department of Internal Medicine, Section Hematology/Oncology, Academic Hospital Maastricht, The Netherlands
  • ,
  • Marjan Van Dijk

      Affiliations

    • Department of Internal Medicine, Section Oncology, Academic Hospital Maastricht, The Netherlands
  • ,
  • Ilse Verdonck

      Affiliations

    • Limburg Oncology Centre – Hasselt, Belgium
  • ,
  • Frank Buntinx

      Affiliations

    • Leuven Centre of Cancer Prevention, University Hospitals - Leuven, Belgium
    • Department of General Practice and Research Institute Caphri, Maastricht University, The Netherlands

,Accepted 10 December 2009.

References 

  1. Repetto L, Balducci L. A case for geriatric oncology. Lancet Oncol. 2002;3:289–297
  2. Massa E, Madeddu C, Astara G, Pisano M, Spiga C, Tanca FM, et al. An attempt to correlate a “Multidimensional Geriatric Assessment” (MGA), treatment assignment and clinical outcome in elderly cancer patients: results of a phase II open study. Crit Rev Oncol Hematol. 2008;66(1):75–83
  3. Burdette-Radoux S, Muss HB. Adjuvant chemotherapy in the elderly: whom to treat, what regimen?. Oncologist. 2006;11:234–242
  4. de Vries M, van Weert JC, Jansen J, Lemmens VE, Maas HA. Step by step development of clinical care pathways for older cancer patients: necessary or desirable?. Eur J Cancer. 2007;43:2170–2178
  5. Rodin MB, Mohile SG. A practical approach to geriatric assessment in oncology. J Clin Oncol. 2007;25:1936–1944
  6. Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55:241–252
  7. Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007;25:1824–1831
  8. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198
  9. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17:37–49
  10. Gosney M. Contribution of the geriatrician to the management of cancer in older patients. Eur J Cancer. 2007;43:2153–2160
  11. Maas HA, Janssen-Heijnen ML, Olde Rikkert MG, Machteld Wymenga AN. Comprehensive geriatric assessment and its clinical impact in oncology. Eur J Cancer. 2007;43:2161–2169
  12. Overcash JA, Beckstead J, Moody L, Extermann M, Cobb S. The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: scoring and interpretation. Crit Rev Oncol Hematol. 2006;59:205–210
  13. Overcash JA, Beckstead J, Extermann M, Cobb S. The abbreviated comprehensive geriatric assessment (aCGA): a retrospective analysis. Crit Rev Oncol Hematol. 2005;54:129–136
  14. Saliba D, Elliott M, Rubenstein LZ, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49:1691–1699
  15. Min LC, Elliott MN, Wenger NS, Saliba D. Higher vulnerable elders survey scores predict death and functional decline in vulnerable older people. J Am Geriatr Soc. 2006;54:507–511
  16. Schuurmans H, Steverink N, Lindenberg S, Frieswijk N, Slaets JP. Old or frail: what tells us more?. J Gerontol A Biol Sci Med Sci. 2004;59:M962–M965
  17. Rothman KJ, Greenland S. Modern epidemiology. Philadelphia: Lippincott William and Wilkins; 1998;
  18. StataCorp . Stata. (8.0). College Station, TX: StataCorp.; 2003;[Ref Type: Computer Program]
  19. Misset JL, Bauer C. What is an “elderly” oncologic patient?. Crit Rev Oncol Hematol. 2008;67:62–63
  20. Terret C. How and why to perform a geriatric assessment in clinical practice. Ann Oncol. 2008;19(Suppl. 7):vii300–vii303
  21. Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist. 2000;5:224–237
  22. Mohile SG, Bylow K, Dale W, et al. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer. 2007;109:802–810
  23. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61–65
  24. Lawton MP. Scales to measure competence in everyday activities. Psychopharmacol Bull. 1988;24:609–614

PII: S1040-8428(09)00247-9

doi: 10.1016/j.critrevonc.2009.12.002

Critical Reviews in Oncology / Hematology
Volume 75, Issue 3 , Pages 243-248 , September 2010